Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN7 SHORT NOTE 5M

Classify the immunosuppressant drugs. Describe the calcineurin inhibitors and the complications of immunosuppression.

Pharmacology · 2nd Professional — Para-Clinical

Classification of Immunosuppressants

ClassDrugsMechanism
Calcineurin inhibitorsCiclosporin, tacrolimusBind cyclophilin and FKBP respectively, and the complex inhibits calcineurin, so NFAT cannot activate IL-2 transcription — T-cell activation fails. The backbone of transplant immunosuppression
MTOR inhibitorsSirolimus (rapamycin), everolimusBlock the mTOR pathway and so IL-2-driven T-cell proliferation; not nephrotoxic, so useful where renal function is a concern
AntiproliferativeAzathioprine, mycophenolate mofetilAzathioprine is converted to 6-mercaptopurine and inhibits purine synthesis; mycophenolate inhibits inosine monophosphate dehydrogenase, on which lymphocytes depend selectively for purine synthesis
CorticosteroidsPrednisolone, methylprednisoloneBroad suppression of cytokine transcription; used for induction, maintenance and rejection episodes
CytotoxicCyclophosphamide, methotrexateVasculitis, lupus nephritis, and severe autoimmune disease
BiologicalsBasiliximab (anti-IL-2 receptor), antithymocyte globulin, rituximab (anti-CD20), belatacept, anti-TNF agents, tocilizumabInduction therapy, steroid-resistant rejection, and autoimmune disease
JAK inhibitorsTofacitinib, baricitinibAutoimmune disease

Calcineurin Inhibitors in Detail

  • Narrow therapeutic index requiring level monitoring — too little causes rejection, too much causes nephrotoxicity, and the window between them is small
  • Nephrotoxicity is the central problem — both acute (reversible afferent arteriolar constriction) and chronic (irreversible interstitial fibrosis); paradoxically, the drug that saves a transplanted kidney also damages it
  • Ciclosporin — additionally causes gum hypertrophy, hirsutism, hypertension, hyperlipidaemia, hyperkalaemia, hypomagnesaemia and tremor
  • Tacrolimus — more potent, and now generally preferred; causes less hirsutism and gum change but more diabetes (post-transplant diabetes mellitus), neurotoxicity and alopecia
  • Both are metabolised by CYP3A4, so interactions are numerous and clinically serious — levels are raised by azoles, macrolides, diltiazem, verapamil and grapefruit juice, and lowered by rifampicin, phenytoin, carbamazepine and ST JOHN wort

CLINICAL PEARL

An interaction that changes a calcineurin inhibitor level can cost the patient the graft. Add rifampicin and the level collapses, and rejection follows; add an azole antifungal and the level soars, and the kidney is damaged. This is why every new prescription for a transplant patient — including antibiotics, antifungals and herbal preparations — must be checked against the immunosuppressant, and why patients are told never to take anything without asking.

Complications of Immunosuppression

  • Infection — the dominant risk: bacterial, and opportunistic organisms including cytomegalovirus, Pneumocystis, fungi, tuberculosis, and reactivation of hepatitis B and herpes viruses. Prophylaxis with co-trimoxazole and valganciclovir is routine
  • Malignancy — particularly skin cancer and post-transplant lymphoproliferative disease (EBV-driven); the risk relates to the total burden and duration of immunosuppression
  • Drug-specific toxicity — nephrotoxicity, diabetes, hypertension, dyslipidaemia, bone loss, marrow suppression
  • Mycophenolate is teratogenic, causing characteristic malformations; pregnancy must be excluded and contraception used, and it is switched to azathioprine before a planned pregnancy
  • Live vaccines are contraindicated; inactivated vaccines should be given before transplantation wherever possible

Applied Aspects

  • Check every new drug against the immunosuppressant before prescribing for a transplant patient, and warn them explicitly about over-the-counter and herbal preparations
  • Screen for tuberculosis and hepatitis B before starting any prolonged immunosuppression — essential in India, where the background prevalence makes reactivation a real and frequently fatal event
  • Never allow a transplant patient to run out of medication; a few missed days can cause irreversible rejection, and cost or supply interruption is a genuine cause of graft loss in India
  • Take fever seriously and investigate broadly; the usual inflammatory signs are blunted and the differential includes organisms that would not trouble a normal host
  • Advise sun protection and annual skin examination, given the substantially raised risk of skin malignancy
  • Check TPMT before azathioprine and never combine it at full dose with allopurinol, which blocks its inactivation by xanthine oxidase and causes profound marrow suppression

All questions in Blood, Haematinics & Anticancer Drugs

  1. Q1Define haematinics. Describe iron metabolism, iron preparations, vitamin B12 and folic acid with their uses. ★
  2. Q2Classify the haemostatic drugs. Describe vitamin K, tranexamic acid and the treatment of haemophilia. ★
  3. Q3Describe the general principles of cancer chemotherapy including the cell cycle, log kill hypothesis, combination therapy, resistance and toxicity. ★
  4. Q4Classify the cytotoxic anticancer drugs. Describe the alkylating agents, antimetabolites and natural products with their distinctive toxicities. ★
  5. Q5Describe the hormonal agents, targeted therapy and immunotherapy used in cancer. ★
  6. SN1Describe oral and parenteral iron therapy with the monitoring of response and the management of iron overload. ★
  7. SN2Describe vitamin B12 and folic acid with their deficiency states and treatment. ★
  8. SN3Describe the haematopoietic growth factors with their uses and adverse effects. ★
  9. SN4Describe methotrexate with its mechanism, uses, adverse effects and interactions. ★
  10. SN5Describe cisplatin and the platinum compounds with their uses and toxicity. ★
  11. SN6Describe the adverse effects of cancer chemotherapy and their prevention and management. ★
  12. SN7Classify the immunosuppressant drugs. Describe the calcineurin inhibitors and the complications of immunosuppression.

Every Pharmacology chapter →

Scroll to Top